Skip to Content

MOXAID SR 250MG PROLONGED-RELEASE CAPSULE HARD

Active substance(s): ACETAZOLAMIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
Uncommon side effects (probably occuring in less than 1 in 100 people) are:
treatment is stopped.
• depression
• drowsiness or confusion
• low Platelet count
• a loss of interest in sex
• decrease in cells production responsible
• ringing in the ears or difficulty in hearing
for providing immunity
• temporary
short-sightedness
which
• low potassium levels
subsides when the dosage is reduced or
Rare cases (probably occuring in less than 1 in 1000 people) of skin rashes including an
increased sensitivity to sunlight have been reported. If you experience any unusual skin rashes,
inform your doctor.
If you take Moxaid SR Capsules for a long time it can occasionally affect the amount of
potassium, or sodium in your blood. Your doctor will probably take blood tests to check that this
does not happen. You might also experience bone thinning or the risk of kidney stones with
long-term therapy. High or low blood sugar levels may occasionally occur.
If any of the side effects becomes serious, or if you notice any side effects not listed in
this leaflet, please tell your doctor or pharmacist.
Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card
Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine

PATIENT INFORMATION LEAFLET

MoxaidTM

Read all of this leaflet carefully before you start taking this medicine.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to others. It may harm them,
even if their symptoms are the same as yours.
If any of the side effects become serious, or if you notice any side effects not listed in this
leaflet, please tell your doctor or pharmacist.
The name of your medicine is Moxaid SR 250mg prolonged-release capsules. It will be
referred to as Moxaid SR capsules for ease of use hereafter.
In this leaflet:
1. What Moxaid SR Capsules are and what they are used for
2. Before you take Moxaid SR Capsules
3. How to take Moxaid SR Capsules
4. Possible side effects
5. How to store Moxaid SR Capsules
6. Further information

5. HOW TO STORE MOXAID SR 250MG CAPSULES
Store below 30°C.
Store in the original package in order to protect from light and moisture.
Keep out of the reach and sight of children.
Do not use after the expiry date. This date is printed on your pack.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how
to dispose of medicines no longer required. These measures will help to protect the environment.

1. WHAT MOXAID SR CAPSULES ARE AND WHAT ARE THEY USED FOR

REMEMBER
This medicine is for you. Only a doctor can prescribe it for you. Never give this medicine to
someone else; it could harm them, even if their symptoms seem the same as yours.

Moxaid SR Capsules contain the active substance Acetazolamide. This belongs to a group of
medicines known as carbonic anhydrase inhibitors.
Moxaid SR Capsules are used to treat, glaucoma (a condition of the eye), by reducing the
pressure within the eye.

6. FURTHER INFORMATION

2. BEFORE YOU TAKE MOXAID SR CAPSULES

What Moxaid SR Capsules Contain
The active substance is Acetazolamide. Each capsule contains acetazolamide.
The other ingredients are microcrystalline cellulose (E460), sodium lauryl sulphate, purified water,
ethylcellulose, hydroxypropyl methylcellulose (E464), mineral oil, opaspray K-1R-2506 orange
[hydroxypropyl cellulose, titanium dioxide (E171), FD & C yellow No.6 (E110)].
Capsule shell contains gelatin, titanium dioxide (E171), yellow iron oxide (E172) and erythrosine (E127).
What Moxaid SR Capsules look like and contents of the pack
Moxaid SR Capsules have a clear body and orange cap, and are printed with ‘GS 250’ in black.
They usually come in blister packs of 28 or 30 capsules.
Marketing Authorisation Holder:
Mercury Pharmaceuticals Ltd., No. 1 Croydon, 12-16 Addiscombe Road, Croydon CR0 0XT, UK
Manufacturer:
Mercury Pharmaceuticals Ltd., No. 1 Croydon, 12-16 Addiscombe Road, Croydon CR0 0XT, UK
Moxaid is a trademark of Amdipharm International Limited
This leaflet was last revised in September 2014

SR 250mg Prolonged-release capsules
(Acetazolamide)

DO NOT take Moxaid SR Capsules if:
• you know you are allergic to sulphonamides, sulphonamide derivatives including
acetazolamide or to any of the ingredients in the capsules (listed in Section 6 at the end of
this leaflet)
• you have severe liver problems
• you have or have ever had severe kidney problems
• you have a particular type of glaucoma known as chronic non congestive angle closure
glaucoma (your doctor will be able to advise you)
• you have reduced function of the adrenal glands – glands above the kidneys - (also known
as Addison’s disease)
• you have low blood levels of sodium and/or potassium or high blood levels of chlorine (your
doctor will advise you)
• the person this medicine has been prescribed for is under the age of 12.
Speak to your doctor if any of the above applies to you.
Take special care and speak to your doctor before taking Moxaid SR Capsules if:
• you have or have ever had kidney problems such as kidney stones

XXXXX/LF/1

4

1

Date of Approval:

PROOF

8

To be implemented by:

17/17/2014
Product Description:

Originated by

Date:

Moxaid SR 250mg Capsules

SMT

31/07/2013 No

Tech Approved

Component:

Revised by

Version:

Leaflet

PAT

XXXXXX/LF/1

Manufacturer:

File Name:

CRF No.:

Tilomed

XXXXXXLF MoxaidSR 250mg Capsules v1_8 QA.CRF.107.2013

Market:

Software Package:

Barcode:

UK

Quark Xpress 10

N/A

Minimum Font Size & Typeface:

Dimensions:

Pharma Code:

8.5pt Swiss 721BT

157.5 x 195mm

N/A

Colours: Black

Key Line:

M

Date:

continued over








you have lung problems such as chronic bronchitis or emphysema, which cause difficulty in
breathing
you have diabetes or problems with your blood sugar level
you are over the age of 65
a small number of people being treated with anti-epileptics such as Acetazolamide have had
thoughts of harming or killing themselves, if at any time you have these thoughts,
immediately contact your doctor.



If you take more Moxaid SR Capsules than you should:
Get medical help immediately, either by calling your doctor or going to the nearest hospital
casualty department. Take any remaining tablets and this leaflet with you so that the medical
staff know exactly what you have taken.
If you forget to take your Moxaid SR Capsules:
You should take it as soon as you remember. However, if this is within 2 hours of your next dose you
should skip the missed capsule and carry on taking the rest of your capsules as usual.
DO NOT take a double dose of capsules to make up the missed dose.
If you have any further questions about these tablets, ask your doctor or pharmacist.

Taking other medicines
Moxaid SR 250mg Capsules may affect some medical tests. If you visit a hospital or clinic
for any medical tests, you should tell the doctor concerned that you are taking Moxaid SR
Capsules.
Please tell your doctor or pharmacist if you are taking or have recently taken any other
medicines, including medicines obtained without a prescription. The effects of any of these
medicines may change, particularly if you are taking, or using, any of the following:
• medicines for your heart such as cardiac glycosides (e.g. digoxin)
• medicines to reduce blood pressure
• medicines to thin your blood (e.g. warfarin)
• medicines to lower the sugar in your blood
• medicines for epilepsy or fits (in particular, phenytoin, primidone or carbamazepine or
topiramate)
• drugs which interfere with folic acid, e.g. methotrexate, pyrimethamine, or trimethoprim
• steroids such as prednisolone
• aspirin and related medicines, e.g. salicylic acid or choline salicylate for mouth ulcers
• other drugs in the group of medicines called carbonic anhydrase inhibitors
• amphetamines (a stimulant), quinidine (treats an irregular heart beat), methenamine
(prevents urine infections) or lithium (treats severe mental problems)
• sodium bicarbonate therapy
• ciclosporin (used to suppress the immune system).
Pregnancy and breast feeding
Ask your doctor or pharmacist for advice before taking any medicines.
Moxaid SR Capsules SHOULD NOT be taken if you are pregnant, think you are pregnant or are
planning to become pregnant. It may be taken when breast feeding but only on the advice of
the doctor.
Driving and using machines
If Moxaid SR Capsules make you feel drowsy or confused you should not drive or operate
machines. Moxaid SR Capsules can occasionally cause short-sightedness; if this happens and
you feel that you can no longer drive safely, you should stop driving and contact your doctor.
Important information about some of the ingredients of Moxaid SR Capsules
This medicine contains the ingredient sunset yellow FCF (E110) which may cause allergic
reactions.

4. POSSIBLE SIDE EFFECTS
Like all medicines, Moxaid SR Capsules can cause side effects, although not everybody gets them.
All medicines can cause allergic reactions although serious allergic reactions are very rare.
Any sudden wheeziness, difficulty in breathing, swelling of the eyelids, face or lips, rash or
itching (especially affecting your whole body) should be reported to a doctor immediately.
Tell your doctor immediately if you notice any of the following side effects:
• fever, severe chills, sore throat or mouth ulcers
• bruises or tiny red or purple spots on your skin
• a severe condition of the skin that may affect the mouth and other parts of the body. This
may progress to a severe skin reaction which starts with painful red areas, then large blisters
and ends up with peeling of layers of skin, mouth, nose, eyes or genitals. This may be
accompanied by fever and chills, aching muscles and generally feeling unwell
• your muscles feel weak or paralysis, and reduced muscle tone
• you have fits
• pain or burning when you pass urine, have difficulty in passing urine or you stop passing
urine, or have blood in your urine
• your stools are black or tarry, or if you notice blood in your stools.
• nausea, vomiting, loss of appetite, feeling generally unwell, itching, yellowing of the skin and
eyes, and dark colour urine
• decrease in the number of red blood cells. tiredness, headaches, being short of breath when
exercising, dizziness and looking pale
• decrease in white blood cells
• Softening of bones when used along with drugs used to treat fits/ convulsions
• kidney problems.
Tell your doctor as soon as possible if you notice any of the following side effects:
• pain in your lower back
• pale stools
• your skin or eyes look slightly yellow.
You may also experience the following:
Common side effects (probably occuring in less than 1 in 10 people) are:
• low blood sugar
• looking flushed
• headache
• a need to pass urine more often than
• diarrhoea
normal
• feeling or being sick, loss of appetite, • tiredness or irritability
thirst, or a metallic taste in the mouth
• feeling over-excited
• dizziness, loss of full control of arms or • a tingling or numbness in the fingers or
legs
toes, or coldness in the extremities.

3. HOW TO TAKE MOXAID SR 250MG CAPSULES





Before starting and during treatment your doctor will monitor your blood to check that
treatment with Moxaid SR Capsules is suitable for you
Moxaid SR Capsules are not for use in children.

Always take the number of capsules your doctor has told you to take. This information will
also be on the label
The usual recommended dosage is 1 or 2 capsules a day taken just before or just after a meal
Moxaid SR Capsules should be swallowed whole with a drink of water. Do not chew or crush
the capsules
The dose varies from person to person depending on their condition. If you are not sure how
many capsules to take or when to take them, ask your pharmacist

2

3

Date of Approval:

PROOF

7

To be implemented by:

28/08/2014
Product Description:

Originated by

Date:

Moxaid SR 250mg Capsules

SMT

31/07/2013 No

Tech Approved

Component:

Revised by

Version:

Leaflet

ADD

XXXXXX/LF/1

Manufacturer:

File Name:

CRF No.:

Tilomed

XXXXXXLF MoxaidSR 250mg Capsules v1_7 QA.CRF.107.2013

Market:

Software Package:

Barcode:

UK

Quark Xpress 10

N/A

Minimum Font Size & Typeface:

Dimensions:

Pharma Code:

8.5pt Swiss 721BT

157.5 x 195mm

N/A

Colours: Black

Key Line:

M

Date:

continued over

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide